Skip to content
PoliticalRepoPoliticalRepo

Subjects · United States

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

1,551 records in US in 2023

Records

Bill· HRH.R. 1276 (118th)referred

Protect Minors from Medical Malpractice Act of 2023

United States · United States Congress · 1 March 2023

Protect Minors from Medical Malpractice Act of 2023 This bill makes a medical practitioner who performs a gender-transition procedure on an individual who is less than 18 years of age liable for any physical, psychological, emotional, or physiological harms from the procedure for 30 years after the individual turns 18. Additionally, if a state requires medical practitioners to perform gender-transition procedures, that state shall be ineligible for federal funding from the Department of Health and Human Services. Gender-transition procedures generally include certain surgeries or hormone therapies that change the body of an individual to correspond to a sex that is discordant with the individual's biological sex. They exclude, however, interventions to treat (1) individuals who either have ambiguous external biological sex characteristics or lack a normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action; (2) infections, injuries, diseases, or disorders caused by a gender-transition procedure; or (3) a physical disorder, injury, or illness that places an individual in imminent danger of death or impairment of a major bodily function.

Bill· HRH.R. 1315 (118th)referred

PC–CARE Act

United States · United States Congress · 1 March 2023

Prostate Cancer Community Assistance, Research and Education Act of 2023 or the PC-CARE Act This bill establishes a committee to develop, implement, and periodically revise a plan to coordinate federal activities and programs concerning prostate cancer, including those related to research, screening, diagnosis, and treatment. Committee members must include representatives from specified federal agencies, as well as researchers, clinicians, individuals living with prostate cancer (or their caregivers), and other stakeholders. In addition, at least half of the members must be physicians.

Bill· HRH.R. 1316 (118th)referred

Save Children’s Coverage Act

United States · United States Congress · 1 March 2023

Save Children's Coverage Act This bill allows states to provide for extended coverage under Medicaid and the Children's Health Insurance Program (CHIP) of children after the end of the COVID-19 public health emergency. It also allows for extended Medicaid coverage of certain low-income, formerly homeless, or formerly incarcerated adults. Specifically, after the emergency period ends, states may provide for continued Medicaid or CHIP coverage of children under the age of six until the child turns six or is no longer a resident of the state, whichever is earlier. For children ages 6 to 18, the state may provide for continued coverage for two years after the child is deemed eligible, until the child turns 19, or until the child is no longer a resident of the state, whichever is earlier. States may also provide for continued Medicaid coverage of adults whose income does not exceed 28% of the federal poverty line or who were homeless or incarcerated in a prison or psychiatric hospital within the two years prior to applying for Medicaid; coverage may be provided for 12 months after the individual is deemed eligible or until the individual is no longer a resident, whichever is earlier. The bill also requires states to annually review the demographics of Medicaid enrollees, including contact information, as a condition of receiving a waiver from Medicaid requirements (e.g., Section 1115 demonstration waivers) after the emergency period ends.

Bill· HRH.R. 1326 (118th)referred

SALT Act

United States · United States Congress · 1 March 2023

Supporting Americans with Lower Taxes Act or the SALT Act This bill modifies the cap on state and local tax deductions (the SALT deduction) and provides for Medicare coverage of hearing and vision services. Current law caps the SALT deduction at $10,000 for single taxpayers and married couples filing jointly and $5,000 for married taxpayers filing separately; the cap applies to tax years 2018 through 2025. The bill permanently (1) eliminates any cap for single taxpayers or married couples filing jointly who make less than $400,000 a year ($200,000 for married taxpayers filing separately); (2) increases the cap to $60,000 for single taxpayers or married couples filing jointly who make $400,000 or more a year ($30,000 for married taxpayers filing separately who make $200,000 or more a year); and (3) phases down the cap for filers who make more than $400,000 in a manner such that those who make $1 million or more do not qualify for the deduction. The bill also provides for Medicare coverage of hearing and vision services, including hearing aids, glasses, and contact lenses, beginning in 2025. It also appropriates any amounts received as a result of the bill's changes to the SALT cap to Medicare's Supplementary Medical Insurance Trust Fund and provides for specific fund transfers for FY2024 and FY2025 to support Medicare hearing and vision coverage.

Bill· HRH.R. 1294 (118th)referred

9/11 Responder and Survivor Health Funding Correction Act of 2023

United States · United States Congress · 1 March 2023

9/11 Responder and Survivor Health Funding Correction Act of 2023 This bill modifies the funding of, expands eligibility for, and makes other changes to the World Trade Center Health Program. This program provides medical monitoring and treatment to responders and survivors who suffer from health conditions related to the terrorist attacks on September 11, 2001. Specifically, the bill provides additional funding for the program through FY2033 to cover program costs. It also sets out a new formula to determine funding amounts for the program from FY2034 through FY2090. Additionally, the bill expands eligibility for the program to include members of the Armed Forces and federal employees and contractors who provided rescue, recovery, demolition, debris clean-up, or related services in response to the attacks at the Pentagon and in Shanksville, PA on September 11, 2001. The bill limits the enrollment of newly eligible individuals in the program to 500 at any given time. Other changes in the bill include (1) allowing certain health care providers other than physicians to determine whether an individual's health condition is related to an attack, and (2) making the program administrator (rather than the centers that collect and analyze health data generated from the program) responsible for establishing criteria for credentialing health care providers that participate in the program.

Bill· HRH.R. 1280 (118th)referred

Cerebral Palsy Research Program Authorization Act of 2023

United States · United States Congress · 1 March 2023

Cerebral Palsy Research Program Authorization Act of 2023 This bill requires the Centers for Disease Control and Prevention to carry out a research program that addresses diagnosis and treatment, public health surveillance, and other aspects of cerebral palsy (a group of disorders caused by abnormal brain development or brain damage that affects an individual's ability to move and maintain balance and posture).

Bill· HRH.R. 1273 (118th)referred

Peace Corps Reauthorization Act of 2023

United States · United States Congress · 1 March 2023

Peace Corps Reauthorization Act of 2023 This bill requires or authorizes various policies for the Peace Corps program. For example, the bill increases the minimum rate for readjustment allowances paid to Peace Corps volunteers upon their return to the United States; requires the Peace Corps to establish processes to return volunteers to service after their service has been interrupted by a mandatory evacuation, and to strive to allow evacuated volunteers to return to the country in which they had formerly been assigned (except for Peace Corps missions in China); requires the Peace Corps to provide separating volunteers with information on postservice health care options; provides statutory authority to an executive order that provides returning volunteers with noncompetitive eligibility for federal employment purposes (i.e., eligibility to be noncompetitively appointed to a competitive federal position); requires the Peace Corps to implement a zero-tolerance policy regarding volunteer or trainee involvement with illegal drugs; requires the Peace Corps to take all reasonable measures to prevent and address reprisal or retaliation against a volunteer by any person with supervisory authority over the volunteer, such as a Peace Corps officer; and authorizes suspension without pay for employees engaged in serious misconduct that could impact the efficiency of the service and could lead to removal for cause.

Bill· HRH.R. 1328 (118th)referred

Medical Device Nonvisual Accessibility Act of 2023

United States · United States Congress · 1 March 2023

Medical Device Nonvisual Accessibility Act of 2023 This bill requires certain medical devices with a digital interface to meet nonvisual accessibility standards established by the Food and Drug Administration (FDA). Specifically, the FDA must establish regulations to require a Class II or Class III medical device with a digital interface to provide a blind or low-vision user access to the same services and information, and generally the same ease of use, as provided to a user who is not low-vision or blind. (The FDA classifies medical devices in three classes. Class I devices are low-risk, Class II devices are moderate-risk, and Class III devices are high-risk.) A Class II or Class III medical device that does not meet the nonvisual accessibility standards established under this bill may not be sold. However, the FDA may waive the bill's requirements for a device upon a showing that applying the standards would fundamentally alter the nature of the device or create an undue hardship for the manufacturer. The bill also does not apply to devices that are intended solely for use by a health care provider or in a setting outside the home.

Bill· HRH.R. 1297 (118th)referred

To amend title 10, United States Code, to prohibit the Secretary of Defense from paying or reimbursing expenses relating to abortion services, and for other purposes.

United States · United States Congress · 1 March 2023

This bill prohibits the Department of Defense (DOD) from providing certain funding related to abortion services. Specifically, the bill prohibits DOD from paying or reimbursing any fees or expenses for a health care professional (who provides health care at a military medical treatment facility) to gain a license in a state if the purpose of gaining the license is to provide abortion services. The bill also repeals the DOD memorandum titled Ensuring Access to Reproductive Health Care (October 20, 2022). Such memo sets forth DOD policies and procedures in response to the Supreme Court's ruling in Dobbs v. Jackson Women's Health Organization . Under the bill, DOD may not obligate or expend funds to carry out the memo or any successor memo.

Bill· SS. 604 (118th)referred

Changing the Culture of the FDA Act

United States · United States Congress · 1 March 2023

Changing the Culture of the FDA Act This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)

Bill· SS. 574 (118th)referred

Increasing Prescription Drug Competition Act

United States · United States Congress · 1 March 2023

Increasing Prescription Drug Competition Act This bill provides that certifications in generic drug applications of certain patents involved in Risk Evaluation and Mitigation Strategy (REMS) programs have no effect upon the drug's approval. (The Food and Drug Administration sometimes requires a REMS program for certain drugs with safety risks, which may include restrictions on a drug's distribution through elements to ensure safe use (ETASU), such as special requirements for pharmacies that dispense the drug.) Specifically, certifications in generic drug applications with respect to patents that involve an ETASU for REMS requirements have no effect on the effective date of the drug's approval, notwithstanding any other provisions that allow for a stay of approval pending litigation outcomes (i.e., 30-month stay). The bill also specifies that in a civil action alleging patent infringement with respect to REMS requirements, the sponsor of the approved brand-name drug may only seek damages from (rather than an injunction against) the generic drug applicant.

Bill· SS. 606 (118th)referred

Protecting Americans from Dangerous Opioids Act

United States · United States Congress · 1 March 2023

Protecting Americans from Dangerous Opioids Act This bill requires the Food and Drug Administration (FDA) to revoke approval for an opioid drug for every new opioid drug approved. (Opioids are drugs with effects similar to opium, such as certain pain medications.) In determining the drug for which to revoke approval, the FDA must prioritize revoking approval for drugs that are not abuse deterrent and consider the public health impact of drugs on the market.

Bill· SS. 607 (118th)referred

EFFECTIVE Act

United States · United States Congress · 1 March 2023

Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs.

Bill· SS. 603 (118th)referred

FDA Accountability for Public Safety Act

United States · United States Congress · 1 March 2023

FDA Accountability for Public Safety Act This bill establishes additional procedures related to the market approval process for opioids. Under the bill, a Food and Drug Administration (FDA) advisory committee must make recommendations regarding supplemental applications for opioids. Current law requires only that an FDA committee make recommendations on new drug applications. The bill specifies that only the Commissioner of Food and Drugs may approve an opioid-related application against the recommendation of the committee. If the Commissioner approves such an application against a committee recommendation, the Commissioner must submit a report to Congress that includes (1) the evidence regarding patient safety that supports the Commissioner's decision, and (2) a disclosure of any potential conflicts of interest of FDA officials involved in the decision. The Commissioner must also testify before Congress regarding the decision, upon request. The drug in question may not be sold until the Commissioner has submitted the required report.

Bill· HRH.R. 1264 (118th)referred

Commonsense Reporting Act of 2023

United States · United States Congress · 28 February 2023

Commonsense Reporting Act of 2023 This bill addresses the eligibility verification process for the premium assistance tax credit and cost-sharing subsidy under the Patient Protection and Affordable Care Act (PPACA). It requires the Department of the Treasury to develop and implement a reporting system that allows employers to voluntarily report information about their health plans for the current plan year prior to the beginning of open enrollment. The bill also allows electronic transmission of employee and enrollee statements and permits Treasury to accept full names and dates of birth in lieu of dependents' and spouses' Social Security account numbers. The bill also allows certain large employers who do not offer their employees minimum health care coverage 90 days to appeal an assessment for not providing such coverage. The Government Accountability Office must evaluate (1) for the period beginning on January 1, 2015, and ending on December 31, 2022, the notification of employers by PPACA exchanges of the eligibility of employees for advance payments of the premium assistance tax credit or cost-sharing subsidies; and (2) for calendar year 2024, the functionality of the prospective reporting system established by this bill, including the accuracy of information collected.

Resolution· HRESH.Res. 185 (118th)referred

Declaring racism a public health crisis.

United States · United States Congress · 28 February 2023

This resolution declares racism a public health crisis and supports efforts to address health disparities and inequities across all sectors.

Bill· SS. 543 (118th)referred

CCM–CARE Act of 2023

United States · United States Congress · 28 February 2023

Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2023 or the CCM-CARE Act of 2023 This bill requires the National Institutes of Health (NIH) and other agencies to expand and coordinate their efforts to research cerebral cavernous malformation. (Cerebral cavernous malformation is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, and bleeding in the brain.) The NIH must (1) award grants for medical, clinical, and pharmacological research; (2) award grants to support a network of clinical research centers intended to develop a cure for the condition; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients. The Centers for Disease Control and Prevention must award grants to research entities for collecting and reporting data about cerebral cavernous malformation. The Food and Drug Administration must accelerate the clinical trial process for cerebral cavernous malformation by supporting (1) appropriate laboratory indicators of the condition, (2) the qualification of clinical outcome measures related to quality of life, (3) investigational drug applications, and (4) expedited peer-review pathways.

Bill· SS. 570 (118th)referred

Medicaid Dental Benefit Act of 2023

United States · United States Congress · 28 February 2023

Medicaid Dental Benefit Act of 2023 This bill requires state Medicaid programs to cover dental and oral health services for adults. It also increases the Federal Medical Assistance Percentage (i.e., federal matching rate) for such services. The Centers for Medicare & Medicaid Services must develop oral health quality and equity measures and conduct outreach relating to such coverage. Additionally, the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission must report on specified information relating to adult oral health care.

Bill· SS. 569 (118th)referred

9/11 Responder and Survivor Health Funding Correction Act of 2023

United States · United States Congress · 28 February 2023

9/11 Responder and Survivor Health Funding Correction Act of 2023 This bill modifies the funding of, expands eligibility for, and makes other changes to the World Trade Center Health Program. This program provides medical monitoring and treatment to responders and survivors who suffer from health conditions related to the terrorist attacks on September 11, 2001. Specifically, the bill provides additional funding for the program through FY2033 to cover program costs. It also sets out a new formula to determine funding amounts for the program from FY2034 through FY2090. Additionally, the bill expands eligibility for the program to include members of the Armed Forces and federal employees and contractors who provided rescue, recovery, demolition, debris clean-up, or related services in response to the attacks at the Pentagon and in Shanksville, PA on September 11, 2001. The bill limits the enrollment of newly eligible individuals in the program to 500 at any given time. Other changes in the bill include (1) allowing certain health care providers other than physicians to determine whether an individual's health condition is related to an attack, and (2) making the program administrator (rather than the centers that collect and analyze health data generated from the program) responsible for establishing criteria for credentialing health care providers that participate in the program.

Bill· SS. 565 (118th)referred

Pregnancy Center Security Act

United States · United States Congress · 28 February 2023

Pregnancy Center Security Act This bill requires the Department of Health and Human Services to award grants on a competitive basis for upgrading the facilities of pregnancy-help organizations. The bill defines these as organizations that provide services to individuals with unintended pregnancies with the intent of encouraging the individuals to give birth; the definition in the bill excludes, however, organizations that perform or refer for abortions (or affiliates of those organizations). Facility upgrades include installing security systems and making the facilities accessible to people with disabilities. The bill prohibits the use of grant funds for abortion-related services.

Bill· SS. 549 (118th)referred

DAIRY PRIDE Act

United States · United States Congress · 28 February 2023

Defending Against Imitations and Replacements of Yogurt, Milk, and Cheese To Promote Regular Intake of Dairy Everyday Act or the DAIRY PRIDE Act This bill prohibits the sale of any food that uses the market name of a dairy product (such as milk , yogurt , or cream cheese ) unless the food (1) is the milk of a hooved animal, (2) is derived from such milk, or (3) contains such milk as a primary ingredient.

Bill· HRH.R. 1209 (118th)open

FOCA Act of 2023

United States · United States Congress · 27 February 2023

Fair and Open Competition Act or the FOCA Act This bill prohibits federal construction contracts or controlling documents for federally supported construction projects from requiring or prohibiting project labor agreements. Such documents also may not discriminate against or give preference to a bidder or contractor who signs or refuses to sign a project labor agreement. An agency may exempt a project from this prohibition to avert an imminent threat to public health or safety or to serve the national security.

Bill· HRH.R. 1199 (118th)open

Facilitating Innovative Nuclear Diagnostics Act of 2023

United States · United States Congress · 27 February 2023

Facilitating Innovative Nuclear Diagnostics Act of 2023 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Resolution· HRESH.Res. 170 (118th)referred

Recognizing it is the congressional intent of the Affordable Care Act that enhanced Federal medical assistance percentage funds are to be directly shared with the counties in States with a Medicaid local share requirement.

United States · United States Congress · 27 February 2023

This resolution recognizes that states that require local governments to contribute funds to Medicaid should not withhold federal Medicaid matching funds from these local governments to make up for state budget shortfalls.

Bill· HRH.R. 1210 (118th)referred

Stop Fentanyl Border Crossings Act

United States · United States Congress · 27 February 2023

Stop Fentanyl Border Crossings Act This bill authorizes the Department of Health and Human Services (HHS) to restrict migration and imports from foreign countries to prevent the introduction of illicit drugs into the United States. Current law authorizes HHS to restrict migration and imports from foreign countries to prevent the introduction of communicable diseases. Under this bill, HHS may also restrict migration and imports from a country if HHS determines that the existence of substantial illicit drug smuggling from that country poses a risk to public health.

Bill· HRH.R. 1224 (118th)referred

INFO for Reproductive Care Act of 2023

United States · United States Congress · 27 February 2023

Informing New Factors and Options for Reproductive Care Act of 2023 or the INFO for Reproductive Care Act of 2023 This bill requires the Department of Health and Human Services to carry out a campaign to educate health care professionals (and health care professions students) about assisting patients to navigate legal issues related to abortions and other reproductive health care services.

Resolution· HRESH.Res. 172 (118th)referred

Expressing support for designation of March 3, 2023, as "National Triple-Negative Breast Cancer Day".

United States · United States Congress · 27 February 2023

This resolution expresses support for the designation of National Triple-Negative Breast Cancer Day. Triple-negative breast cancer is a distinct form of cancer that does not have the hormone and protein receptors commonly found in breast cancer. As a result, triple-negative breast cancer does not respond to hormone therapy or medicines that target those receptors.

Bill· HRH.R. 1215 (118th)referred

Healthcare Worker Retention Act

United States · United States Congress · 27 February 2023

Healthcare Worker Retention Act This bill establishes through 2024 a new refundable health care worker tax credit, equal to $1,000 for individual taxpayers (1) who work in a healthcare setting as an employee or contractor for at least an average of 20 hours per week, and 3 months during each half of a taxable year; and (2) whose gross income does not exceed $100,000 ($200,000 for joint returns or for a surviving spouse). The bill defines healthcare setting as an organization that provides healthcare services in specified settings, including a hospital, a nursing home, a community-based healthcare center, a school or college campus, a primary care facility, an assisted living facility, a hospice or home care, emergency medical services, or any other licensed facility that extends healthcare services to patients, including the elderly and disabled. The bill directs the Internal Revenue Service to establish a program to make semiannual advance payments of healthcare worker tax credit amounts.

Bill· HRH.R. 1201 (118th)referred

Increasing Behavioral Health Treatment Act

United States · United States Congress · 27 February 2023

Increasing Behavioral Health Treatment Act This bill repeals restrictions that generally prohibit federal payment under Medicaid for services provided in institutions for mental diseases (IMDs) for individuals under the age of 65. (Currently, states may receive payment for such services through certain mechanisms, such as through a Medicaid demonstration waiver.) The bill also requires state Medicaid programs that cover IMD services to improve patient access to outpatient and community-based behavioral health care, expand crisis stabilization services, facilitate care coordination between providers and first responders, and report specified information relating to IMD utilization and costs.

Bill· SS. 537 (118th)referred

FOCA Act

United States · United States Congress · 27 February 2023

Fair and Open Competition Act or the FOCA Act This bill prohibits federal construction contracts or controlling documents for federally supported construction projects from requiring or prohibiting project labor agreements. Such documents also may not discriminate against or give preference to a bidder or contractor who signs or refuses to sign a project labor agreement. An agency may exempt a project from this prohibition to avert an imminent threat to public health or safety or to serve the national security.

Bill· HRH.R. 1166 (118th)open

Public Health Emergency Medical Supplies Enhancement Act of 2023

United States · United States Congress · 24 February 2023

Public Health Emergency Medical Supplies Enhancement Act of 2023 This bill expands certain authorities under the Defense Production Act of 1950 (DPA) to respond to public health emergencies. Specifically, during a public health emergency, any medical equipment or supplies determined by the Department of Health and Human Services or the Department of Homeland Security to be scarce and critical materials essential to the national defense may be deemed as such by the President, and funds available to implement the DPA may be used for the purchase, production, or distribution of such medical equipment or supplies. Further, during a public health emergency, the President and federal agencies may take specific actions to support the production of such materials or supplies, including with respect to supply chains, private-sector coordination, needs assessments, and overall strategies. The bill provides for enhanced reporting under the DPA during a public health emergency. Additionally, a report required under the DPA for FY2023 and FY2024 shall include the percentage of contracts awarded to small businesses.

Bill· HRH.R. 1182 (118th)open

Veterans Serving Veterans Act of 2023

United States · United States Congress · 24 February 2023

Veterans Serving Veterans Act of 2023 This bill updates the Department of Veterans Affairs (VA) current recruiting database by requiring the VA to maintain a single searchable database to be known as the Departments of Defense and Veterans Affairs Recruitment Database . With respect to vacant positions for critical jobs or mental health professionals, the database must list (1) the military occupational specialty or skill that corresponds to the position, and (2) each qualified member of the Armed Forces who may be recruited to fill the position before such qualified member has been discharged and released from active duty. Qualified members of the Armed Forces are those service members who (1) are being separated or recently separated from active duty, (2) elect to be listed in the database, and (3) have been determined by the VA to have a military occupational specialty. The database must list the following for each qualified member of the Armed Forces: name, contact information, expected discharge date, and military occupational specialty. The VA must implement direct hiring and appointment procedures for vacant database positions and may authorize relocation bonuses. The bill also requires the VA to train and certify veterans who served as basic health care technicians in the Armed Forces to work as VA intermediate care technicians.

Bill· HRH.R. 1191 (118th)referred

Correcting Guam’s History in the PACT Act

United States · United States Congress · 24 February 2023

Correcting Guam's History in the PACT Act This bill expands eligibility for a presumption of service-connection for specified diseases associated with exposure to certain herbicide agents. Under a presumption of service-connection, specific conditions diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded. Under the bill, service performed in Guam or its territorial waters between August 15, 1958, and July 31, 1980, provides a veteran who has a specified disease that is associated with exposure to certain herbicide agents with eligibility for a presumption of service-connection. (Under current law, the eligible time frame for service in Guam is between January 9, 1962, and July 31, 1980.)

Bill· HRH.R. 1173 (118th)referred

Patients’ Right to Know Their Medication Act of 2023

United States · United States Congress · 24 February 2023

Patients' Right to Know Their Medication Act of 2023 This bill establishes requirements relating to the form, content, and distribution of patient safety labels for prescription drugs. Specifically, the Food and Drug Administration must issue regulations with requirements relating to the authorship, content, format, color, printing, and dissemination of such patient safety information. The regulations must require labels to include the drug's approved uses, known interactions with other drugs or substances, contact information for the drug's manufacturer, and other specified information relating to patient safety. The information must be in plain, neutral language and must be given in printed form with each prescription.

Bill· HRH.R. 1113 (118th)referred

Easy Enrollment in Health Care Act

United States · United States Congress · 21 February 2023

Easy Enrollment in Health Care Act This bill revises the procedures related to enrollment in health insurance affordability programs, including Medicaid, the Children's Health Insurance Program (CHIP), and state-operated Basic Health Programs. The bill provides funding to support the changes. Specifically, the bill permits individuals who do not have minimum essential coverage to, in conjunction with filing their tax return, determine whether any members of their household are eligible for an insurance affordability program and enroll in minimum essential coverage. The bill makes individuals eligible for Medicaid or CHIP based on a prior finding of eligibility for the Temporary Assistance for Needy Families program or the Supplemental Nutrition Assistance Program. Additionally, the bill provides access to certain information to support enrollment in insurance affordability programs.

Bill· HRH.R. 1129 (118th)referred

Rural ER Access Act

United States · United States Congress · 21 February 2023

Rural ER Access Act This bill requires the Centers for Medicare & Medicaid Services to repeal regulations that require off-campus facilities to be located within 35 miles of the main hospital or critical access hospital in order to receive provider-based status under Medicare (i.e., to be considered as hospital outpatient departments for purposes of Medicare payment).

Bill· HRH.R. 1128 (118th)referred

Rural Health Care Access Act of 2023

United States · United States Congress · 21 February 2023

Rural Health Care Access Act of 2023 This bill eliminates certain criteria that hospitals must meet in order to qualify as critical access hospitals that receive special payment under Medicare. Specifically, the bill eliminates the requirement that a hospital must either (1) be located more than 35 miles (15 miles in mountainous regions or areas with only secondary roads) from another hospital, or (2) have been certified prior to January 1, 2006, by the state as a necessary provider of services in the area.

Bill· HRH.R. 1110 (118th)referred

KEEP Telehealth Options Act of 2023

United States · United States Congress · 21 February 2023

Knowing the Efficiency and Efficacy of Permanent Telehealth Options Act of 2023 or the KEEP Telehealth Options Act of 2023 This bill requires the Centers for Medicare & Medicaid Services to report on telehealth expansion under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) during the COVID-19 public health emergency and through December 31, 2024. The report must include information relating to the types of services available, the utilization of services, and the effects on public health. The Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission must also report on any improvements or barriers with respect to such expanded services, as well as any associated risks of fraudulent activity.

Bill· HRH.R. 1114 (118th)referred

Long COVID RECOVERY NOW Act

United States · United States Congress · 21 February 2023

Long COVID Response is Care Optimized and Vitally Essential Resources that Yield New Opportunities for Wellness Act or the Long COVID RECOVERY NOW Act This bill establishes grants and requires actions to support treatment, research, and other efforts to address Long COVID (persistent, long-term symptoms following recovery from acute COVID-19 infection). Specifically, the bill establishes grants for treating individuals with Long COVID. These include grants for certain health clinics and primary care providers to treat patients, including by addressing food insecurity and other social needs that could interfere with treatment; health care providers or public health departments to set up or expand specialized clinics or programs using a multidisciplinary approach; and primary care providers to support the development of evidence and other resources related to treatments. The bill also establishes grants for Long COVID patient registries and research on Long COVID in pediatric populations. Additionally, the Office of the National Coordinator for Health Information Technology must convene stakeholders to identify best practices to make de-identified data related to Long COVID available to researchers. The office must also recommend policies for data standardization and related approaches to further a greater understanding of Long COVID. Further, the Department of Health and Human Services must (1) set up a website to educate health care providers and the public about Long COVID, and (2) issue guidance on ways to assist individuals with Long COVID through Medicaid and the Children's Health Insurance Program (CHIP). The bill also expands access for treating Long COVID through Medicaid, CHIP, and the Community Mental Health Services Block Grant.

Bill· HRH.R. 1117 (118th)referred

Advancing Safe Medications for Moms and Babies Act of 2023

United States · United States Congress · 21 February 2023

Advancing Safe Medications for Moms and Babies Act of 2023 This bill establishes programs and requirements to support the inclusion of pregnant and lactating women in clinical research. For example, the bill requires the Department of Health and Human Services to align the Food and Drug Administration's regulations for human subjects in clinical trials with other departmental regulations for pregnant women in clinical research. The bill also establishes (1) a national online clearinghouse with information about clinical trials that enroll pregnant and lactating women, (2) an advisory committee to help coordinate federal activities with respect to clinical research for pregnant and lactating women, and (3) an educational campaign on the importance of including pregnant and lactating women in clinical research. The National Institutes of Health must also prioritize certain research projects on new and existing medications for pregnant and lactating women based on need, feasibility, and the potential impact of the research.

Bill· HRH.R. 1057 (118th)referred

Imported Seafood Safety Standards Act

United States · United States Congress · 17 February 2023

Imported Seafood Safety Standards Act This bill prohibits the importation of any seafood from a foreign country unless the country complies with U.S. standards for seafood manufacturing, processing, and holding. Among other requirements, the bill requires an annual inspection of each foreign facility that exports seafood to the United States to ensure compliance with U.S. standards.

Bill· HRH.R. 1079 (118th)referred

Medicaid Work Requirements Act

United States · United States Congress · 17 February 2023

Medicaid Work Requirements Act This bill establishes work requirements under Medicaid for able-bodied adults. Specifically, the bill requires individuals who are between the ages of 18 and 65 and who are not otherwise unable to work due to a medical condition, family situation, or other listed reason to work at least 120 hours per month, participate in a work program or volunteer at least 80 hours per month, or some combination of these at least 80 hours per month, based on a monthly average, in order to qualify for Medicaid.

Bill· HRH.R. 1066 (118th)referred

CARING for Social Determinants Act of 2023

United States · United States Congress · 17 February 2023

Collecting and Analyzing Resources Integral and Necessary for Guidance for Social Determinants Act of 2023 or the CARING for Social Determinants Act of 2023 This bill requires the Centers for Medicare & Medicaid Services to periodically update specified guidance to help states address social determinants of health (e.g., socioeconomic factors) under Medicaid and the Children's Health Insurance Program (CHIP).

Bill· HRH.R. 1090 (118th)referred

DEVICE Act of 2023

United States · United States Congress · 17 February 2023

Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2023 or the DEVICE Act of 2023 This bill addresses design changes and reprocessing of medical devices. (Reprocessing of medical devices is the process for cleaning and sterilizing or disinfecting devices for reuse.) Specifically, medical device manufacturers must notify the Food and Drug Administration (1) before making changes to the design or reprocessing instructions of a device, and (2) no more than five days after widely disseminating to health care providers in a foreign country communications regarding changes to the design or reprocessing instructions of a device or regarding a safety concern about a device. A device may not be sold if the manufacturer violates these notification requirements.

PreviousPage 31 of 32Next